Txoj Kev Siv Txoj Kev thiab Kev: Kev Koom Tes, Kev Sib Haum Xeeb thiab Yeej-Yeej
cov khoom

Cov khoom

Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS: 328086-60-8

Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate yog ib qho tshuaj uas muaj cov mis molecular C15H24N2O5. Nws muaj ib lub pob txha caj qaum propanoate nrog ib pawg Boc-amino txuas rau lub carbon thib 2 thiab ib pawg 2-oxo-3-pyrrolidinyl ntawm lub carbon thib 3 hauv ib qho chiral configuration.


Cov Khoom Qhia Txog Khoom

Cov Cim Npe Khoom

Daim Ntawv Thov thiab Cov Nyhuv:

Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate yog siv ua ib qho tseem ceeb rau kev tsim cov peptide derivatives thiab cov tshuaj sib xyaw. Nws cov pab pawg ua haujlwm tshwj xeeb thiab stereochemistry muab kev nkag mus rau cov peptides nyuaj thiab peptidomimetics nrog cov khoom siv bioactivity thiab cov khoom zoo li tshuaj. Cov kws tshawb fawb siv nws cov yam ntxwv ntawm cov qauv los qhia cov amino acid residues thiab heterocyclic moieties rau hauv peptide sequences, modulating lawv cov kev sib cuam tshuam biological thiab lub hom phiaj tshwj xeeb. Cov tshuaj pom cov ntawv thov hauv peptide chemistry, qhov twg nws ua haujlwm ua lub tsev thaiv rau peptide synthesis, solid-phase peptide sib dhos, thiab peptide tshuaj tsim. Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate ua rau kev tsim cov peptide libraries, peptide mimetics, thiab peptide-based therapeutics tsom mus rau ntau txoj hauv kev biological thiab molecular targets. Nws lub luag haujlwm hauv kev hloov kho peptide thiab kev ua kom zoo dua pab txhawb rau kev tsim cov tshuaj tshiab, kev kuaj mob, thiab cov cuab yeej biochemical. Hauv kev lag luam tshuaj, Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate yog siv rau hauv kev tsim cov tshuaj peptidic, peptide conjugates, thiab peptide-based prodrugs. Nws txoj kev koom tes hauv kev tshawb fawb peptide thiab kev tshawb pom tshuaj ua rau muaj kev tshawb nrhiav peptide-mediated signaling, receptor interactions, thiab kev kho mob hauv cov cheeb tsam xws li oncology, immunology, thiab neurology. Los ntawm kev koom ua ke cov tshuaj no rau hauv cov qauv peptide, cov kws tshawb fawb tuaj yeem txhim kho cov khoom pharmacokinetic, kev ruaj khov ntawm lub cev, thiab lub hom phiaj ntawm peptide-based pharmaceuticals, nthuav dav qhov ntau thiab tsawg ntawm peptide therapeutics thiab kev kho mob tus kheej.

Qauv Khoom:

Cov hmoov amino acid1
Cov hmoov amino acid 2

Khoom Ntim:

Cov hmoov amino acid 3
Cov hmoov amino acid4
Cov hmoov amino acid 5
Cov hmoov amino acid 6

Cov Lus Qhia Ntxiv:

Kev sau ua ke C15H24N2O5
Kev Ntsuas 99%
Qhov tsos hmoov dawb
CAS Nr. 328086-60-8
Ntim khoom Me me thiab ntau
Lub Neej Txee 2 xyoos
Kev Khaws Cia Khaws cia rau qhov chaw txias thiab qhuav
Daim Ntawv Pov Thawj ISO.

 


  • Yav dhau los:
  • Tom ntej no:

  • Sau koj cov lus ntawm no thiab xa tuaj rau peb